Comparative cerebrospinal fluid diffusion of imipenem and meropenem in rats

Journal of Pharmacy and Pharmacology

Volumn 52, Issue 9, 2000, Pages 1143-1150

  Dupuis, A ^a   Caillaud, A ^a   Pariat, C ^a   Courtois, P ^a   Couet, W ^a   Bouquet, S ^a  

^a Faculte de Medicine et de Pharmacie   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CILASTATIN PLUS IMIPENEM; IMIPENEM; MEROPENEM;

ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; BLOOD CEREBROSPINAL FLUID BARRIER; CEREBROSPINAL FLUID; COMPARATIVE STUDY; CONTROLLED STUDY; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG CEREBROSPINAL FLUID LEVEL; DRUG DIFFUSION; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG INFUSION; MALE; NONHUMAN; RAT; STEADY STATE;

EID: 0033798131     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357001774912     Document Type: Article

References (36)

1. Imipenem/cilastatin: A reappraisal of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy
2. Review of adverse experiences and tolerability in the first 2,516 patients treated with imipenem/cilastatin
3. Determination of imipenem in human plasma, urine and tissue by high-performance liquid chromatography
4. Imipenem/cilastatin: A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy
5. Penetration of meropenem into cerebrospinal fluid of patients with inflamed meninges
6. Physiological parameters in laboratory animals and humans
7. Pharmacokinetic-pharmacodynamic contributions to the convulsant activity of pefloxacin and norfloxacin in rats
8. Pharmacokinetic-pharmacodynamic contributions to the convulsant activity of fluoroquinolones in rats
9. Comparative convulsant potencies of two carbapenem derivatives in C57 and DBA/2 mice
10. An overview of the pharmacology of imipenem/cilastatin
11. Rapid and sensitive determination of meropenem in rat plasma by high performance liquid chromatography
12. Imipenem but not meropenem induces convulsions in DBA/2 mice unrelated to cerebrospinal fluid concentrations
13. In vitro antibacterial activity of SM-7338, a carbapenem antibiotic with stability to dehydropeptidase I. Antimicrob. Agents Chemother.
14. Stability of meropenem and the effect of 1β-methyl substitution on its stability in the presence of renal dehydropeptidase-I
15. Nonlinear distribution of atenolol between plasma and cerebrospinal fluid
16. The disposition and metabolism of meropenem in laboratory animals and man
17. Penetration of imipenem and other antibiotics into inflammatory exudate and their efficacy in pseudomonas infection in the rat granuloma pouch model
18. Cerebrospinal fluid penetration of imipenem and cilastatin (Primaxin) in children with central nervous system infections
19. Activity of a new carbapenem antibiotic, meropenem, against Haemophilus influenzae strains with β-lactamase stability and non-enzyme mediated resistance to ampicillin
20. Activity of meropenem against antibiotics-resistant or infrequently encountered Gram-negative bacilli
21. Carbapenem treatment of meningitis
22. Penetration of imipenem and cilastatin into cerebrospinal fluid of patients with bacterial meningitis
23. Disposition and elimination of meropenem in cerebrospinal fluid of hydrocephalic patients with external ventriculostomy
24. Pharmacokinetics of meropenem compared to imipenem-cilastatin in young, healthy males
25. Disposition of radiolabeled imipenem and cilastatin in normal human volunteers
26. Safety profile of meropenem: International clinical experience based on the first 3125 patients treated with meropenem
27. Pharmacokinetics and bacteriological efficacy of N-formimidoyl thienamycin in experimental Escherichia coli meningitis
28. Meropenem, evidence of lack of proconvulsive tendency in mice
29. Structural features resulting activity of carbapenem compounds: Effect of C-2 side chain
30. Transport of imipenem, a novel carbapenem antibiotic, in the rat central nervous system
31. Pharmacokinetics of N-formimidoyl thienamycin and influence of a renal dipeptidase inhibitor in experimental meningitis
32. Meropenem. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy
33. Methods for evaluating the penetration of β-lactam antibiotics into tissues
34. Imipenem/cilastatin treatment of bacterial meningitis in children
35. Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations